Psychopharmacoendocrinology and Depression Research
Autor Gregor Laakmannen Limba Engleză Paperback – 5 oct 1990
Preț: 712.25 lei
Preț vechi: 749.73 lei
-5% Nou
Puncte Express: 1068
Preț estimativ în valută:
136.30€ • 140.82$ • 113.38£
136.30€ • 140.82$ • 113.38£
Carte tipărită la comandă
Livrare economică 19 martie-02 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783540520757
ISBN-10: 3540520759
Pagini: 232
Ilustrații: XII, 219 p.
Dimensiuni: 155 x 235 x 12 mm
Greutate: 0.33 kg
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3540520759
Pagini: 232
Ilustrații: XII, 219 p.
Dimensiuni: 155 x 235 x 12 mm
Greutate: 0.33 kg
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchCuprins
1 Introduction.- 1.1 Outline of the Study.- 1.2 Effect of Psychotropic Drugs on Central Nervous Aminergic Stimuli Transmission.- 1.3 Influence of Aminergic Neuronal Systems on Anterior Pituitary Hormone Secretion.- 1.4 Aminergic Neurons, APH Secretion and Depression Research.- 2 Influence of Psychotropic Drugs on Anterior Pituitary Hormone Secretion in Healthy Subjects.- 2.1 Healthy Subjects and Methods.- 2.2 Influence of Psychotropic Drugs on GH Secretion.- 2.3 Influence of Psychotropic Drugs on Prolactin Secretion.- 2.4 Influence of Psychotropic Drugs on Cortisol/ACTH Secretion.- 2.5 Discussion.- 3 Influence of Receptor Blockers and Receptor Agonists on Antidepressant-Induced Anterior Pituitary Hormone Secretion in Healthy Subjects.- 3.1 Healthy Subjects and Methods.- 3.2 Influence of Receptor Blockers and Receptor Agonists on DMI-Induced GH Stimulation.- 3.3 Influence of Receptor Blockers and Receptor Agonists on DMI-Induced PRL Stimulation.- 3.4 Influence of Receptor Blockers and Receptor Agonists on DMI-Induced Cortisol/ACTH Stimulation.- 3.5 Discussion.- 4 Desipramine-Induced Growth Hormone Stimulation in Depressive Patients and Healthy Subjects.- 4.1 GH Secretion after Desipramine in Depressive Patients and Healthy Subjects.- 4.2 Healthy Subjects, Patients, and Methods.- 4.3 Results.- 4.4 Summary and Discussion.- 5 Summary.- 6 Reference.